Literature DB >> 25764275

Aetiology and risk factors of community-acquired pneumonia in hospitalized patients in Norway.

Wenche Røysted1, Øystein Simonsen2, Andrew Jenkins3,4, Marjut Sarjomaa5, Martin Veel Svendsen6, Eivind Ragnhildstveit7, Yngvar Tveten8,9, Anita Kanestrøm7, Halfrid Waage10, Jetmund Ringstad2.   

Abstract

BACKGROUND AND AIMS: In Norway, data on the aetiology of community-acquired pneumonia (CAP) in hospitalized patients are limited. The aims of this study were to investigate the bacterial aetiology of CAP in hospitalized patients in Norway, risk factors for CAP and possible differences in risk factors between patients with Legionnaire's disease and pneumonia because of other causes.
METHODS: Adult patients with radiologically confirmed CAP admitted to hospital were eligible for the study. Routine aerobic and Legionella culture of sputum, blood culture, urinary antigen test for Legionella pneumophila and Streptococcus pneumoniae, polymerase chain reaction detection of Chlamydophila pneumoniae, Mycoplasma pneumoniae and Bordetella pertussis from throat specimens, and serology for L. pneumophila serogroup 1-6 were performed. A questionnaire, which included demographic and clinical data, risk factors and treatment, was completed.
RESULTS: We included 374 patients through a 20-month study period in 2007-2008. The aetiological agent was detected in 37% of cases. S. pneumoniae (20%) was the most prevalent agent, followed by Haemophilus influenzae (6%) and Legionella spp. (6%). Eight Legionella cases were diagnosed by urinary antigen test, of which four also had positive serology. In addition, 13 Legionella cases were diagnosed by serology. The degree of comorbidity was high. An increased risk of hospital-diagnosed Legionella pneumonia was found among patients with a diagnosis of chronic congestive heart failure.
CONCLUSION: Our results indicate that S. pneumoniae is the most common bacterial cause of pneumonia in hospitalized patients, and the prevalence of Legionella pneumonia is probably higher in Norway than recognized previously.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  Legionella; Norway; bacterial pneumonia; community-acquired infections; risk factors

Mesh:

Year:  2015        PMID: 25764275     DOI: 10.1111/crj.12283

Source DB:  PubMed          Journal:  Clin Respir J        ISSN: 1752-6981            Impact factor:   2.570


  8 in total

1.  An audit and feedback intervention study increased adherence to antibiotic prescribing guidelines at a Norwegian hospital.

Authors:  June Utnes Høgli; Beate Hennie Garcia; Frode Skjold; Vegard Skogen; Lars Småbrekke
Journal:  BMC Infect Dis       Date:  2016-02-27       Impact factor: 3.090

2.  Cost-Effectiveness of Vaccinating Immunocompetent ≥65 Year Olds with the 13-Valent Pneumococcal Conjugate Vaccine in England.

Authors:  Albert Jan van Hoek; Elizabeth Miller
Journal:  PLoS One       Date:  2016-02-25       Impact factor: 3.240

3.  Rapid syndromic PCR testing in patients with respiratory tract infections reduces time to results and improves microbial yield.

Authors:  D Markussen; M Ebbesen; S Serigstad; H M S Grewal; Ø Kommedal; L Heggelund; C H van Werkhoven; D Faurholt-Jepsen; T W Clark; C Ritz; E Ulvestad; R Bjørneklett; S T Knoop
Journal:  Sci Rep       Date:  2022-01-10       Impact factor: 4.379

4.  Diagnostic stewardship aiming at expectorated or induced sputum promotes microbial diagnosis in community-acquired pneumonia.

Authors:  Jan Kristian Damås; Lars Heggelund; Bjørn Waagsbø; Eva Margrethe Buset; Jørn-Åge Longva; Merete Bjerke; Birgitte Bakkene; Anne-Stine Ertesvåg; Hanne Holmen; Marko Nikodojevic; To Thy Tran; Andreas Christensen; Einar Nilsen
Journal:  BMC Infect Dis       Date:  2022-03-02       Impact factor: 3.090

5.  Impact of rapid molecular testing on diagnosis, treatment and management of community-acquired pneumonia in Norway: a pragmatic randomised controlled trial (CAPNOR).

Authors:  Sondre Serigstad; Christian Ritz; Daniel Faurholt-Jepsen; Dagfinn Markussen; Marit H Ebbesen; Øyvind Kommedal; Rune O Bjørneklett; Lars Heggelund; Tristan W Clark; Cornelis H van Werkhoven; Siri T Knoop; Elling Ulvestad; Harleen M S Grewal
Journal:  Trials       Date:  2022-08-01       Impact factor: 2.728

Review 6.  Evolving Understanding of the Causes of Pneumonia in Adults, With Special Attention to the Role of Pneumococcus.

Authors:  Daniel M Musher; Michael S Abers; John G Bartlett
Journal:  Clin Infect Dis       Date:  2017-10-30       Impact factor: 9.079

7.  Empirical prescribing of penicillin G/V reduces risk of readmission of hospitalized patients with community-acquired pneumonia in Norway: a retrospective observational study.

Authors:  June Utnes Høgli; Beate Hennie Garcia; Kristian Svendsen; Vegard Skogen; Lars Småbrekke
Journal:  BMC Pulm Med       Date:  2020-06-15       Impact factor: 3.317

Review 8.  Pertussis in Individuals with Co-morbidities: A Systematic Review.

Authors:  Denis Macina; Keith E Evans
Journal:  Infect Dis Ther       Date:  2021-06-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.